CN116265007A - Anti-drop oil-control and soothing essence and preparation method thereof - Google Patents
Anti-drop oil-control and soothing essence and preparation method thereof Download PDFInfo
- Publication number
- CN116265007A CN116265007A CN202211405303.2A CN202211405303A CN116265007A CN 116265007 A CN116265007 A CN 116265007A CN 202211405303 A CN202211405303 A CN 202211405303A CN 116265007 A CN116265007 A CN 116265007A
- Authority
- CN
- China
- Prior art keywords
- oil
- extract
- essence
- vitamin
- essence according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000000419 plant extract Substances 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 20
- 108010058643 Fungal Proteins Proteins 0.000 claims abstract description 19
- 229940088594 vitamin Drugs 0.000 claims abstract description 13
- 229930003231 vitamin Natural products 0.000 claims abstract description 13
- 235000013343 vitamin Nutrition 0.000 claims abstract description 13
- 239000011782 vitamin Substances 0.000 claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 12
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims abstract description 11
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003242 anti bacterial agent Substances 0.000 claims abstract description 10
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003755 preservative agent Substances 0.000 claims abstract description 10
- 239000002562 thickening agent Substances 0.000 claims abstract description 10
- 239000008367 deionised water Substances 0.000 claims abstract description 8
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 8
- 230000002335 preservative effect Effects 0.000 claims abstract description 8
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 8
- 239000004359 castor oil Substances 0.000 claims abstract description 7
- 235000019438 castor oil Nutrition 0.000 claims abstract description 7
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 7
- 239000003906 humectant Substances 0.000 claims abstract description 6
- 239000000284 extract Substances 0.000 claims description 69
- 239000003921 oil Substances 0.000 claims description 58
- 235000019198 oils Nutrition 0.000 claims description 56
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 30
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 claims description 20
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 18
- 229960002685 biotin Drugs 0.000 claims description 15
- 235000020958 biotin Nutrition 0.000 claims description 14
- 239000011616 biotin Substances 0.000 claims description 14
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 claims description 14
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 claims description 13
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 13
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 claims description 13
- 235000020710 ginseng extract Nutrition 0.000 claims description 13
- 229940041616 menthol Drugs 0.000 claims description 13
- 229940101267 panthenol Drugs 0.000 claims description 13
- 235000020957 pantothenol Nutrition 0.000 claims description 13
- 239000011619 pantothenol Substances 0.000 claims description 13
- 229940015975 1,2-hexanediol Drugs 0.000 claims description 12
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 claims description 12
- 229920002385 Sodium hyaluronate Polymers 0.000 claims description 12
- 235000015724 Trifolium pratense Nutrition 0.000 claims description 12
- 235000013526 red clover Nutrition 0.000 claims description 12
- 229940010747 sodium hyaluronate Drugs 0.000 claims description 12
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 11
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 claims description 10
- 240000000950 Hippophae rhamnoides Species 0.000 claims description 10
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims description 10
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 claims description 10
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims description 10
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 9
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 9
- 229930003427 Vitamin E Natural products 0.000 claims description 9
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 9
- 230000003656 anti-hair-loss Effects 0.000 claims description 9
- 229940036350 bisabolol Drugs 0.000 claims description 9
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 9
- 235000019693 cherries Nutrition 0.000 claims description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 9
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical class NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 claims description 9
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 9
- 235000019165 vitamin E Nutrition 0.000 claims description 9
- 239000011709 vitamin E Substances 0.000 claims description 9
- 229940046009 vitamin E Drugs 0.000 claims description 9
- 239000001243 zingiber officinale rosc. root absolute Substances 0.000 claims description 9
- 239000004475 Arginine Substances 0.000 claims description 8
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 8
- 240000006891 Artemisia vulgaris Species 0.000 claims description 8
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 8
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims description 8
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 7
- 239000001509 sodium citrate Substances 0.000 claims description 7
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 claims description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims description 6
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims description 6
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 claims description 6
- 230000003750 conditioning effect Effects 0.000 claims description 6
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims description 6
- 239000011670 zinc gluconate Substances 0.000 claims description 6
- 229960000306 zinc gluconate Drugs 0.000 claims description 6
- 235000011478 zinc gluconate Nutrition 0.000 claims description 6
- 240000005528 Arctium lappa Species 0.000 claims description 5
- 235000003130 Arctium lappa Nutrition 0.000 claims description 5
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 235000008078 Arctium minus Nutrition 0.000 claims description 4
- -1 ganbazole Chemical compound 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- 229960003966 nicotinamide Drugs 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 241000576429 Forsythia suspensa Species 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 3
- 229960003121 arginine Drugs 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 claims description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims description 2
- 241001289529 Fallopia multiflora Species 0.000 claims description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 2
- 229930003316 Vitamin D Natural products 0.000 claims description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 2
- 235000009697 arginine Nutrition 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims description 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims description 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims description 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims description 2
- 229960004125 ketoconazole Drugs 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 2
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 2
- 235000019166 vitamin D Nutrition 0.000 claims description 2
- 239000011710 vitamin D Substances 0.000 claims description 2
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 2
- 229940045997 vitamin a Drugs 0.000 claims description 2
- 229940046008 vitamin d Drugs 0.000 claims description 2
- 229940043810 zinc pyrithione Drugs 0.000 claims description 2
- PICXIOQBANWBIZ-UHFFFAOYSA-N zinc;1-oxidopyridine-2-thione Chemical compound [Zn+2].[O-]N1C=CC=CC1=S.[O-]N1C=CC=CC1=S PICXIOQBANWBIZ-UHFFFAOYSA-N 0.000 claims description 2
- 229940035437 1,3-propanediol Drugs 0.000 claims 1
- ANZUDYZHSVGBRF-UHFFFAOYSA-N 3-ethylnonane-1,2,3-triol Chemical compound CCCCCCC(O)(CC)C(O)CO ANZUDYZHSVGBRF-UHFFFAOYSA-N 0.000 claims 1
- 241000167854 Bourreria succulenta Species 0.000 claims 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 claims 1
- 244000170916 Paeonia officinalis Species 0.000 claims 1
- 240000002924 Platycladus orientalis Species 0.000 claims 1
- 239000004599 antimicrobial Substances 0.000 claims 1
- 229960003260 chlorhexidine Drugs 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- 239000010656 jasmine oil Substances 0.000 claims 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 claims 1
- 239000003002 pH adjusting agent Substances 0.000 claims 1
- 239000001335 perilla frutescens leaf extract Substances 0.000 claims 1
- 239000010666 rose oil Substances 0.000 claims 1
- 235000019719 rose oil Nutrition 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 6
- 241000555676 Malassezia Species 0.000 abstract description 5
- 210000002374 sebum Anatomy 0.000 abstract description 4
- 210000004761 scalp Anatomy 0.000 description 43
- TXFPEBPIARQUIG-UHFFFAOYSA-N 4'-hydroxyacetophenone Chemical compound CC(=O)C1=CC=C(O)C=C1 TXFPEBPIARQUIG-UHFFFAOYSA-N 0.000 description 20
- 210000003491 skin Anatomy 0.000 description 18
- 210000004209 hair Anatomy 0.000 description 17
- 239000012071 phase Substances 0.000 description 16
- 230000003779 hair growth Effects 0.000 description 13
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 13
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 12
- 201000004384 Alopecia Diseases 0.000 description 12
- 208000024963 hair loss Diseases 0.000 description 12
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 11
- 230000003676 hair loss Effects 0.000 description 11
- 241000246044 Sophora flavescens Species 0.000 description 10
- 229940075285 dandruff control Drugs 0.000 description 10
- 229960005323 phenoxyethanol Drugs 0.000 description 10
- 230000008859 change Effects 0.000 description 9
- 229940100524 ethylhexylglycerin Drugs 0.000 description 9
- 241001290151 Prunus avium subsp. avium Species 0.000 description 8
- 229940063333 burdock root extract Drugs 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 210000003780 hair follicle Anatomy 0.000 description 8
- 240000003243 Thuja occidentalis Species 0.000 description 7
- 235000008109 Thuja occidentalis Nutrition 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 7
- 241000218691 Cupressaceae Species 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 208000001840 Dandruff Diseases 0.000 description 5
- 240000007817 Olea europaea Species 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000006886 Zingiber officinale Nutrition 0.000 description 4
- 229940083428 artemisia argyi leaf extract Drugs 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 235000008397 ginger Nutrition 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 108090001005 Interleukin-6 Proteins 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 244000273928 Zingiber officinale Species 0.000 description 3
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 229960003473 androstanolone Drugs 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 210000000442 hair follicle cell Anatomy 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- MWUXSHHQAYIFBG-UHFFFAOYSA-N nitrogen oxide Inorganic materials O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 3
- 235000019156 vitamin B Nutrition 0.000 description 3
- 239000011720 vitamin B Substances 0.000 description 3
- 239000001841 zingiber officinale Substances 0.000 description 3
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 description 2
- 241001435059 Artemisia argyi Species 0.000 description 2
- 235000010894 Artemisia argyi Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 101710155857 C-C motif chemokine 2 Proteins 0.000 description 2
- 102000000018 Chemokine CCL2 Human genes 0.000 description 2
- 108090000695 Cytokines Proteins 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 241000588724 Escherichia coli Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000015617 Janus Kinases Human genes 0.000 description 2
- 108010024121 Janus Kinases Proteins 0.000 description 2
- 240000005385 Jasminum sambac Species 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- 102100029438 Nitric oxide synthase, inducible Human genes 0.000 description 2
- 101710089543 Nitric oxide synthase, inducible Proteins 0.000 description 2
- 241000736199 Paeonia Species 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 108060008682 Tumor Necrosis Factor Proteins 0.000 description 2
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 2
- 229930003756 Vitamin B7 Natural products 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000002845 discoloration Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229940102465 ginger root Drugs 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- 230000003752 improving hair Effects 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002510 keratinocyte Anatomy 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 229960001790 sodium citrate Drugs 0.000 description 2
- 210000000130 stem cell Anatomy 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 2
- 235000011912 vitamin B7 Nutrition 0.000 description 2
- 239000011735 vitamin B7 Substances 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- MZLKNWMNBXHXMA-UHFFFAOYSA-N 1-phenylheptylbenzene Chemical compound C=1C=CC=CC=1C(CCCCCC)C1=CC=CC=C1 MZLKNWMNBXHXMA-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZIIUUSVHCHPIQD-UHFFFAOYSA-N 2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzenesulfonamide Chemical compound CC1=CC(C)=CC(C)=C1S(=O)(=O)NC1=CC=CC(C(F)(F)F)=C1 ZIIUUSVHCHPIQD-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- 102100033875 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Human genes 0.000 description 1
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 description 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 241000238876 Acari Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 208000035404 Autolysis Diseases 0.000 description 1
- 102000040350 B family Human genes 0.000 description 1
- 108091072128 B family Proteins 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 206010057248 Cell death Diseases 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 101000640851 Homo sapiens 3-oxo-5-alpha-steroid 4-dehydrogenase 2 Proteins 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102100037850 Interferon gamma Human genes 0.000 description 1
- 108010074328 Interferon-gamma Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 108010002350 Interleukin-2 Proteins 0.000 description 1
- 108090000978 Interleukin-4 Proteins 0.000 description 1
- 102000004889 Interleukin-6 Human genes 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 235000007457 Jasminum sambac Nutrition 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 241000191938 Micrococcus luteus Species 0.000 description 1
- 235000017879 Nasturtium officinale Nutrition 0.000 description 1
- 240000005407 Nasturtium officinale Species 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 235000002725 Olea europaea Nutrition 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 240000005001 Paeonia suffruticosa Species 0.000 description 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 description 1
- 240000004371 Panax ginseng Species 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- 241000205407 Polygonum Species 0.000 description 1
- 235000009220 Prunus speciosa Nutrition 0.000 description 1
- 241000198681 Prunus speciosa Species 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 235000000659 Rosa rugosa Nutrition 0.000 description 1
- 240000006066 Rosa rugosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 108010031271 Saccharomyces cerevisiae Proteins Proteins 0.000 description 1
- 241000577483 Salmonella enterica subsp. enterica serovar Paratyphi B Species 0.000 description 1
- 241000607762 Shigella flexneri Species 0.000 description 1
- 206010040844 Skin exfoliation Diseases 0.000 description 1
- 241000191963 Staphylococcus epidermidis Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010044625 Trichorrhexis Diseases 0.000 description 1
- 240000002913 Trifolium pratense Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003571 Vitamin B5 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 241000234314 Zingiber Species 0.000 description 1
- 241000234299 Zingiberaceae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Natural products CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229960002079 calcium pantothenate Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 230000035618 desquamation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000002780 gingerol Nutrition 0.000 description 1
- NLDDIKRKFXEWBK-AWEZNQCLSA-N gingerol Chemical compound CCCCC[C@H](O)CC(=O)CCC1=CC=C(O)C(OC)=C1 NLDDIKRKFXEWBK-AWEZNQCLSA-N 0.000 description 1
- JZLXEKNVCWMYHI-UHFFFAOYSA-N gingerol Natural products CCCCC(O)CC(=O)CCC1=CC=C(O)C(OC)=C1 JZLXEKNVCWMYHI-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000034756 hair follicle development Effects 0.000 description 1
- 230000003661 hair follicle regeneration Effects 0.000 description 1
- 230000003660 hair regeneration Effects 0.000 description 1
- 210000004919 hair shaft Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 230000009916 joint effect Effects 0.000 description 1
- 239000001102 lavandula vera Substances 0.000 description 1
- 235000018219 lavender Nutrition 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- QMHBZWNZCSNBGU-UHFFFAOYSA-N nonane-1,2,3-triol Chemical compound CCCCCCC(O)C(O)CO QMHBZWNZCSNBGU-UHFFFAOYSA-N 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000003658 preventing hair loss Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000000770 proinflammatory effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000004378 sebocyte Anatomy 0.000 description 1
- 230000028043 self proteolysis Effects 0.000 description 1
- 230000001235 sensitizing effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 230000008326 skin blood flow Effects 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229940084750 sophora flavescens root extract Drugs 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000009492 vitamin B5 Nutrition 0.000 description 1
- 239000011675 vitamin B5 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/63—Steroids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/645—Proteins of vegetable origin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9755—Gymnosperms [Coniferophyta]
- A61K8/9761—Cupressaceae [Cypress family], e.g. juniper or cypress
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/008—Preparations for oily hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Cosmetics (AREA)
Abstract
Description
技术领域technical field
本发明涉及护肤品技术领域,尤其涉及IPC A61K8领域,进一步的,涉及一种防脱控油舒缓精华液及其制备方法。The invention relates to the technical field of skin care products, in particular to the field of IPC A61K8, and further relates to an anti-dandruff control oil soothing essence and a preparation method thereof.
背景技术Background technique
随着社会的发展,人们的生活作息、压力水平和饮食习惯都发生了巨大变化,脱发人群数量激增且呈年轻化发展,给人们的身心健康带来了极大影响。脱发会对人们的自信和自尊产生消极作用,从而影响心理健康甚至生活状态。With the development of society, people's daily life, stress level and eating habits have undergone tremendous changes. The number of people with hair loss has increased sharply and is becoming younger, which has brought great impact on people's physical and mental health. Hair loss can negatively affect people's self-confidence and self-esteem, which can affect mental health and even life status.
皮脂腺可以分泌皮脂,皮脂可以保护毛发,锁住皮肤的水分,阻挡一些外界的真菌和杂物。但当头皮油脂大量分泌的情况下,头皮分泌的多余脂质会让马拉色菌大量繁殖,马拉色菌分泌的脂肪酶和磷脂酶水解皮肤的三酰甘油,释放油酸和花生四烯酸等不饱和脂肪酸,破坏表皮角质层屏障功能,并诱导角质形成细胞产生IL-1、IL-2、IL-4、IL-6、IFN-γ、TNF-α等促炎细胞因子,引起皮肤炎症反应和脱屑,炎症最终破坏毛囊和毛囊周围头皮的皮肤,导致脱发。The sebaceous glands can secrete sebum, which can protect the hair, lock the moisture in the skin, and block some external fungi and sundries. However, when the scalp oil is secreted in large quantities, the excess lipid secreted by the scalp will cause Malassezia to multiply. The lipase and phospholipase secreted by Malassezia will hydrolyze the triacylglycerol in the skin, releasing oleic acid and arachidonic acid Unsaturated fatty acids such as acid can destroy the barrier function of the stratum corneum of the epidermis, and induce keratinocytes to produce pro-inflammatory cytokines such as IL-1, IL-2, IL-4, IL-6, IFN-γ, TNF-α, etc., causing skin Inflammatory Response and Desquamation Inflammation eventually destroys the hair follicles and the skin of the scalp around the follicles, leading to hair loss.
中国专利CN 112107527 A公开了一种防脱精华液及其制备方法,其原料包括醇类物质、植物提取物、氢化蓖麻油、增稠剂、透明质酸钠、胜肽和水;此发明提供的防脱精华液,能够同时满足防脱发及促进毛发生长的需求,且其有效成分不易被冲洗掉,对头皮刺激性小,能维持长久的香味,高温贮存稳定性好。但其作用机理单一,防脱发效果不突出。Chinese patent CN 112107527 A discloses an anti-stripping essence and its preparation method. Its raw materials include alcohols, plant extracts, hydrogenated castor oil, thickeners, sodium hyaluronate, peptides and water; this invention provides The anti-hair loss essence can meet the needs of preventing hair loss and promoting hair growth at the same time, and its active ingredients are not easy to be washed off, less irritating to the scalp, can maintain a long-lasting fragrance, and have good storage stability at high temperatures. But its mechanism of action is single, and the anti-hair loss effect is not outstanding.
中国专利CN 114053190 A公开了一种防脱精华液及其制备方法,其原料包括人参提取物、艾叶提取物、牡丹根提取物、獐牙菜提取物、PCA锌、烟酰胺、乙醇、丙二醇和/或甘油和去离子水。此发明的防脱精华液中有效成分的添加量少,且有效成分容易被冲洗掉,添加了高浓度的乙醇,对头皮刺激大。Chinese patent CN 114053190 A discloses an anti-hair loss essence and its preparation method. Its raw materials include ginseng extract, mugwort leaf extract, peony root extract, watercress extract, PCA zinc, nicotinamide, ethanol, propylene glycol and /or glycerin and deionized water. The added amount of active ingredients in the anti-hair loss essence of this invention is small, and the active ingredients are easily washed off, and high concentration of ethanol is added, which is very irritating to the scalp.
发明内容Contents of the invention
为了解决上述问题,本发明第一方面提供了一种防脱控油舒缓精华液,按重量百分比计,其原料包括:1-10%保湿剂、0.9-8%植物提取物A、0.05-5%植物提取物B、0.2-3%抗菌剂、0.005-3%维生素、0.005-2%皮肤调理剂、0.1-1%pH调节剂、0.001-5%水解酵母蛋白、0.05-0.5%增稠剂,去离子水余量;In order to solve the above problems, the first aspect of the present invention provides a kind of anti-shedding oil control soothing essence, and its raw materials include: 1-10% moisturizing agent, 0.9-8% plant extract A, 0.05-5% Plant extract B, 0.2-3% antibacterial agent, 0.005-3% vitamin, 0.005-2% skin conditioner, 0.1-1% pH regulator, 0.001-5% hydrolyzed yeast protein, 0.05-0.5% thickener, The balance of deionized water;
优选地,其原料还包括5-30%乙醇、0.5-10%异十二烷或0.5-5% PEG-40氢化蓖麻油、0.1-1%防腐剂、0.1-0.5%香精。Preferably, its raw materials also include 5-30% ethanol, 0.5-10% isododecane or 0.5-5% PEG-40 hydrogenated castor oil, 0.1-1% preservatives, and 0.1-0.5% essence.
保湿剂的作用是在头皮形成一层锁水保护膜,帮助皮肤角质层储存水分,维持皮肤正常的细胞代谢。The function of the moisturizer is to form a water-locking protective film on the scalp, help the stratum corneum of the skin to store water, and maintain the normal cell metabolism of the skin.
在一些优选的实施方式中,所述保湿剂选自1,2-己二醇、1,3-丙二醇、甘油、辛甘醇、透明质酸钠、海藻糖中的一种或多种组合。In some preferred embodiments, the moisturizing agent is selected from one or more combinations of 1,2-hexanediol, 1,3-propanediol, glycerin, caprylyl glycol, sodium hyaluronate, and trehalose.
在一些优选的实施方式中,所述保湿剂为1,2-己二醇、1,3-丙二醇、辛甘醇和透明质酸钠;所述透明质酸钠分子量为200kDa~400kDa;所述1,2-己二醇、1,3-丙二醇、辛甘醇和透明质酸钠重量比为(0.1-1):(0.5-3):(0.025-0.5):(0.005-0.1);本申请人意外发现,当选择1,2-己二醇、1,3-丙二醇、辛甘醇和透明质酸钠复配作为保湿剂时,不仅可以提高防脱控油舒缓精华液的保湿效果,还可以提高防脱控油舒缓精华液的稳定性。本申请人猜测:1,2-己二醇、1,3-丙二醇、辛甘醇和透明质酸钠能够和乙醇共同作用,促进精华液形成稳定的体系;另外特定分子量的透明质酸钠可以在头皮表面形成一层透明的水化膜,不仅降低了乙醇对头皮的刺激性,同时保证各种植物提取物中有效成分不易被冲洗掉。In some preferred embodiments, the moisturizing agent is 1,2-hexanediol, 1,3-propylene glycol, caprylyl glycol and sodium hyaluronate; the molecular weight of the sodium hyaluronate is 200kDa~400kDa; the 1 , the weight ratio of 2-hexanediol, 1,3-propylene glycol, caprylyl glycol and sodium hyaluronate is (0.1-1):(0.5-3):(0.025-0.5):(0.005-0.1); the applicant Surprisingly, when 1,2-hexanediol, 1,3-propanediol, caprylyl glycol and sodium hyaluronate are selected as the moisturizer, it can not only improve the moisturizing effect of the anti-aging oil control soothing essence, but also improve the anti-aging effect. The stability of oil-free soothing serum. The applicant speculates that: 1,2-hexanediol, 1,3-propanediol, caprylyl glycol and sodium hyaluronate can work together with ethanol to promote the essence to form a stable system; in addition, sodium hyaluronate with a specific molecular weight can be used in A transparent hydration film is formed on the surface of the scalp, which not only reduces the irritation of ethanol to the scalp, but also ensures that the active ingredients in various plant extracts are not easily washed away.
使用植物提取物中的有效成分用于治疗和预防脱发相对安全有效、使用方便。在一些优选的实施方式中,所述植物提取物A选自苦参(Sophora Flavescens)提取物、人参(Panax Ginseng C.A.Mey)提取物、牛蒡(Arctium Lappa L)提取物、侧柏叶(BiotaOrientalis)提取物、姜根(Zingiber Officinale)提取物、红车轴草(TrifoliumPratense)叶提取物、艾(Artemisia Argyi)叶提取物、连翘(Forsythia Suspensa)提取物、牡丹(Paeonia Suffruticosa Andr.)根提取物、何首乌(Fallopia Multiflora(Thunb.)Harald.)根提取物中的一种或多种组合。The active ingredients in plant extracts are relatively safe, effective, and easy to use for the treatment and prevention of hair loss. In some preferred embodiments, the plant extract A is selected from Sophora Flavescens extract, Panax Ginseng C.A.Mey extract, Arctium Lappa L Extract, Ginger Root (Zingiber Officinale) Extract, Red Clover (Trifolium Pratense) Leaf Extract, Artemisia Argyi (Artemisia Argyi) Leaf Extract, Forsythia Suspensa (Forsythia Suspensa) Extract, Peony (Paeonia Suffruticosa Andr.) Root Extract 1. One or more combinations of Polygonum multiflora (Fallopia Multiflora (Thunb.) Harald.) root extract.
在一些优选的实施方式中,所述植物提取物包括苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物、姜根提取物、红车轴草叶提取物和艾叶提取物。In some preferred embodiments, the plant extracts include sophora flavescens extract, ginseng extract, burdock root extract, arborvitae leaf extract, ginger root extract, red clover leaf extract and mugwort leaf extract.
在一些优选的实施方式中,所述苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物、姜根提取物、红车轴草叶提取物、艾叶提取物的重量比为(0.1-2):(0.01-2):(0.05-1):(0.1-0.6):(0.03-0.18):(0.005-0.03):(0.005-0.03)。In some preferred embodiments, the weight ratio of the Sophora flavescens extract, ginseng extract, burdock root extract, arborvitae leaf extract, ginger root extract, red clover leaf extract, and Artemisia argyi leaf extract is (0.1 -2):(0.01-2):(0.05-1):(0.1-0.6):(0.03-0.18):(0.005-0.03):(0.005-0.03).
苦参根提取物中含有一种II型5α-还原酶抑制剂,能够减少双氢睾酮在头皮中的积累,从而减少脱发,提高真皮乳头生长因子的表达,促进毛发生长。Sophora flavescens root extract contains a type II 5α-reductase inhibitor, which can reduce the accumulation of dihydrotestosterone in the scalp, thereby reducing hair loss, increasing the expression of dermal papilla growth factor, and promoting hair growth.
人参提取物中含多种皂甙和多糖类成分,对头皮没有任何的不良刺激,能扩张头皮毛细血管,促进头皮血液循环,增加头皮营养,调节头皮的水油平衡;促进毛囊活力,提高头发韧性,减少脱发、断发;人参提取物也可以抑制5α-还原酶活性,降低皮肤组织中二氢睾酮含量,促进毛发生长。Ginseng extract contains a variety of saponins and polysaccharides, without any adverse stimulation to the scalp, can expand scalp capillaries, promote scalp blood circulation, increase scalp nutrition, adjust the water and oil balance of the scalp; promote hair follicle vitality, improve hair toughness, reduce hair loss and hair breakage; ginseng extract can also inhibit the activity of 5α-reductase, reduce the content of dihydrotestosterone in skin tissue, and promote hair growth.
牛蒡提取物中的有效成分可以降低炎症细胞因子及IL-6和TNF-α的水平;通过抑制Janus激酶(JAK)-信号转导子与转录激活子(STAT)信号传导通路及IL-1β、IL-6和单核细胞趋化蛋白1(MCP-1)的产生,来抑制诱导型NO合酶(iNOS)的表达,从而起到抗炎效果;牛蒡提取物中多酚类物质绿原酸可有效抑制大肠杆菌、金黄色葡萄球菌、枯草杆菌及藤黄微球菌。The active ingredients in burdock extract can reduce the levels of inflammatory cytokines and IL-6 and TNF-α; by inhibiting the Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signal transduction pathway and IL-1β, The production of IL-6 and monocyte chemoattractant protein 1 (MCP-1) to inhibit the expression of inducible NO synthase (iNOS), thereby playing an anti-inflammatory effect; polyphenols chlorogenic acid in burdock extract Can effectively inhibit Escherichia coli, Staphylococcus aureus, Bacillus subtilis and Micrococcus luteus.
侧柏叶提取物中黄酮成分可以激活毛母细胞和促进血液循环,使毛发生长能力衰退的毛囊复活和促进血液循环后补充营养成分而发挥出养发、生发的作用;侧柏叶提取物也可以抑制5a-还原酶活性、作用于皮脂腺细胞,从而减少皮脂的产生;另外侧柏叶提取物还可以抑制头发表皮细胞蜕化的速度、延迟脱落、减少脂溢性皮肤病的产生,达到去屑止痒的效果。The flavonoids in the extract of oriental cypress leaves can activate hair mother cells and promote blood circulation, revive the hair follicles with declining hair growth ability and promote blood circulation to supplement nutrients to play the role of hair nourishment and hair growth; It can inhibit the activity of 5a-reductase and act on sebocytes, thereby reducing the production of sebum; in addition, the extract of oriental cypress leaves can also inhibit the speed of degeneration of hair epidermal cells, delay shedding, reduce the occurrence of seborrheic skin diseases, and achieve anti-dandruff Antipruritic effect.
姜根是姜科姜属植物姜(Zingier offcinale Roscoe)的新鲜根茎,化学成分一般含有挥发油、姜辣素、二苯基庚烷、黄酮类等几类。生姜是民间常用于治疗脱发的中药,生姜油性辛,可加速皮肤血液循环,促进头皮新陈代谢,活化毛囊组织。Ginger root is the fresh rhizome of ginger (Zingier offcinale Roscoe), a plant belonging to Zingiberaceae Zingiberaceae, and its chemical composition generally contains several types such as volatile oil, gingerol, diphenylheptane, and flavonoids. Ginger is a traditional Chinese medicine commonly used in folks to treat hair loss. Ginger is oily and pungent, which can accelerate skin blood circulation, promote scalp metabolism, and activate hair follicle tissue.
红车轴草叶提取物有杀菌作用,对皮屑芽孢菌有较好的抑制效果,可用于抑制头皮油脂的分泌。Red clover leaf extract has a bactericidal effect, and has a good inhibitory effect on dandruff bacillus, and can be used to inhibit the secretion of scalp oil.
艾叶提取物有很好的抑菌抗敏功效,可以有效改善由于头皮螨虫、细菌感染而引起脱发问题。Artemisia argyi leaf extract has good antibacterial and anti-allergic effects, and can effectively improve hair loss problems caused by scalp mites and bacterial infections.
本发明通过苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物、姜根提取物、红车轴草叶提取物、艾叶提取物与水解酵母蛋白共同作用,能够有效抑制头皮油脂的分泌,调节头皮的水油平衡;减少双氢睾酮在头皮中的积累,从而减少脱发,提高真皮乳头生长因子的表达,促进毛发生长;扩张头皮毛细血管,促进头皮血液循环,使毛发生长能力衰退的毛囊复活;进一步探究发现,当苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物、姜根提取物、红车轴草叶提取物、艾叶提取物的重量比为(0.1-2):(0.01-2):(0.05-1):(0.1-0.6):(0.03-0.18):(0.005-0.03):(0.005-0.03)时,制备得到防脱控油舒缓精华液的稳定性较佳。The present invention can effectively inhibit scalp oil production through the joint action of sophora flavescens extract, ginseng extract, burdock root extract, arborvitae leaf extract, ginger root extract, red clover leaf extract, mugwort leaf extract and hydrolyzed yeast protein. Secretion, regulate the water-oil balance of the scalp; reduce the accumulation of dihydrotestosterone in the scalp, thereby reducing hair loss, increase the expression of dermal papilla growth factor, and promote hair growth; expand scalp capillaries, promote scalp blood circulation, and make hair growth decline hair follicle revival; further investigation found that when the weight ratio of Sophora flavescens extract, ginseng extract, burdock root extract, arborvitae leaf extract, ginger root extract, red clover leaf extract, and Artemisia argyi leaf extract is (0.1- 2): (0.01-2): (0.05-1): (0.1-0.6): (0.03-0.18): (0.005-0.03): (0.005-0.03), the stability of the anti-shedding oil control soothing essence is prepared Sex is better.
为了提高防脱控油舒缓精华液的舒缓效果,减轻乙醇对头皮产生的刺激作用,在一些优选的实施方式中,所述植物提取物B包括油橄榄(Olea Europaea)果油、沙棘(Hippophae Rhamnoides)籽油、樱花(Prunus Speciosa)油、薰衣草(LavandulaAngustifolia)油、薄荷脑(Mentha Canadaensis L)、茉莉花(Jasminum Sambac)油、玫瑰花(Rosa Rugosa)油、紫苏(Perilla Frutescens)叶油中的一种或多种组合。In order to improve the soothing effect of the anti-dripping and oil-controlling soothing essence, and alleviate the stimulating effect of ethanol on the scalp, in some preferred embodiments, the plant extract B includes olive (Olea Europaea) fruit oil, seabuckthorn (Hippophae Rhamnoides) seed oil, cherry blossom (Prunus Speciosa) oil, lavender (Lavandula Angustifolia) oil, menthol (Mentha Canadaensis L), jasmine (Jasminum Sambac) oil, rose flower (Rosa Rugosa) oil, perilla (Perilla Frutescens) leaf oil or multiple combinations.
在一些优选的实施方式中,所述植物提取物B包括油橄榄果油、沙棘籽油、樱花油、薰衣草油和薄荷脑;所述油橄榄果油、沙棘籽油、樱花油、薰衣草油、薄荷脑的重量比为(0.1-1):(0.1-1):(0.05-0.4):(0.005-0.5):(0.05-0.5)。其中,油橄榄果油促进血液循环和毛发生长;沙棘籽油中富含的优质脂肪酸,对于加速头发新生,也具有重要作用;樱花油可以平衡头皮油脂,控油祛痘;薰衣草油可以促进头皮的血液循环,有助于控制脱发和促进头发生长;薄荷脑可以促进毛囊角质形成细胞和毛乳头细胞的增殖,使头皮恢复活力;另外薄荷脑还具有杀菌作用,可以帮助对抗头皮屑。In some preferred embodiments, the plant extract B includes olive oil, sea buckthorn seed oil, cherry blossom oil, lavender oil and menthol; the olive oil, sea buckthorn seed oil, cherry blossom oil, lavender oil, menthol The weight ratio is (0.1-1):(0.1-1):(0.05-0.4):(0.005-0.5):(0.05-0.5). Among them, olive fruit oil promotes blood circulation and hair growth; high-quality fatty acids rich in seabuckthorn seed oil also play an important role in accelerating hair regeneration; cherry blossom oil can balance scalp oil, control oil and eliminate acne; lavender oil can promote blood circulation in the scalp circulation, helps to control hair loss and promote hair growth; menthol can promote the proliferation of hair follicle keratinocytes and dermal papilla cells, and rejuvenate the scalp; in addition, menthol also has a bactericidal effect, which can help fight dandruff.
为了抑制头皮表面的马拉色菌的生长,减少头皮屑的产生,在一些优选的实施方式中,所述抗菌剂选自甘草酸二钾、乙基己基甘油、吡罗克酮乙醇胺盐、氯己定、吡啶硫酮锌、甘宝素、酮康唑中一种或多种组合;优选的,所述抗菌剂包括甘草酸二钾、乙基己基甘油和吡罗克酮乙醇胺盐。In order to inhibit the growth of Malassezia on the surface of the scalp and reduce the generation of dandruff, in some preferred embodiments, the antibacterial agent is selected from dipotassium glycyrrhizinate, ethylhexylglycerin, piroctone olamine salt, chlorine One or more combinations of hexidine, zinc pyrithione, campanola, and ketoconazole; preferably, the antibacterial agent includes dipotassium glycyrrhizinate, ethylhexylglycerin, and piroctone olamine salt.
在一些优选的实施方式中,所述甘草酸二钾、乙基己基甘油和吡罗克酮乙醇胺盐的重量比为(0.1-1):(0.1-0.5):(0.05-1)。In some preferred embodiments, the weight ratio of dipotassium glycyrrhizinate, ethylhexylglycerin and piroctone olamine salt is (0.1-1):(0.1-0.5):(0.05-1).
甘草酸二钾对金黄色葡萄球菌、白色葡萄球菌、大肠埃希氏菌、福氏志贺氏菌、乙型副伤寒沙门氏菌等细菌均具有抑菌作用,另外其还具有较强的抗氧化活性;乙基己基甘油可以抑制产生异味的细菌的生长和繁殖,同时不影响有益的皮肤菌群;此外,它可以提高防腐剂苯氧乙醇的功效;吡罗克酮乙醇胺盐既可以有效抑制马拉色菌还可以减轻头皮炎症。Dipotassium glycyrrhizinate has antibacterial effect on Staphylococcus aureus, Staphylococcus albus, Escherichia coli, Shigella flexneri, Salmonella paratyphi B and other bacteria, and it also has strong antioxidant activity ; Ethylhexylglycerin can inhibit the growth and reproduction of odor-causing bacteria without affecting the beneficial skin flora; in addition, it can enhance the efficacy of the preservative phenoxyethanol; piroctone olamine salt can effectively inhibit malaria Chromobacteria can also reduce scalp inflammation.
维生素在正常的毛囊发育和免疫细胞功能中起着重要的作用。为了提高防脱控油舒缓精华液的防脱控油效果,在一些优选的实施方式中,所述维生素选自泛醇、生物素、维生素E、维生素A、维生素D中的一种或多种组合。优选的,所述维生素包括泛醇、生物素和维生素E。The vitamin plays an important role in normal hair follicle development and immune cell function. In order to improve the anti-dripping and oil-controlling effect of the soothing essence, in some preferred embodiments, the vitamin is selected from one or more combinations of panthenol, biotin, vitamin E, vitamin A, and vitamin D. Preferably, the vitamins include panthenol, biotin and vitamin E.
在一些优选的实施方式中,所述泛醇、生物素和维生素E的重量比为(0.1-1):(0.0005-0.1):(0.1-1)。In some preferred embodiments, the weight ratio of panthenol, biotin and vitamin E is (0.1-1):(0.0005-0.1):(0.1-1).
泛醇可以穿透发干和头发的根部,在酶的作用下很快还原成为维生素B5,从而为头发提供额外的B族维生素,有助于增厚头发,促进头发生长。Panthenol can penetrate the hair shaft and the root of the hair, and is quickly reduced to vitamin B5 under the action of enzymes, thus providing additional B vitamins to the hair, helping to thicken the hair and promote hair growth.
生物素又称维生素H、辅酶R,是水溶性维生素,也属于维生素B族,B7。它是合成维生素C的必要物质,是脂肪和蛋白质正常代谢不可或缺的物质。生物素可以促进头发生长和头皮新陈代谢,使头发呈现自然光泽,抑制头油分泌,减少头发掉落。Biotin, also known as vitamin H and coenzyme R, is a water-soluble vitamin and also belongs to the vitamin B family, B7. It is a necessary substance for the synthesis of vitamin C and is indispensable for the normal metabolism of fat and protein. Biotin can promote hair growth and scalp metabolism, make hair appear natural luster, inhibit scalp oil secretion, and reduce hair fall.
维生素E可以抵抗毛发衰老,促进毛母细胞分裂,使毛发生长,减少头发掉落。Vitamin E can resist hair aging, promote hair mother cell division, make hair grow and reduce hair fall.
在一些优选的实施方式中,所述皮肤调理剂选自精氨酸、葡糖酸锌、烟酰胺、红没药醇中的一种或多种组合;优选的,所述皮肤调理剂包括精氨酸和红没药醇。In some preferred embodiments, the skin conditioning agent is selected from one or more combinations of arginine, zinc gluconate, nicotinamide, and bisabolol; preferably, the skin conditioning agent includes amino acid and bisabolol.
在一些优选的实施方式中,所述精氨酸和红没药醇的重量比为(0.005-0.5):(0.05-0.3)。In some preferred embodiments, the weight ratio of arginine to bisabolol is (0.005-0.5): (0.05-0.3).
头发生长需要氮氧化物,精氨酸能够参与氮化合物的产生,另外它还可以扩张头皮中的血管,增加输送到毛囊的营养和氧气量;红没药醇在皮肤皮层有高渗透性,作用是常用渗透剂的几十倍,能够促进酵母分解蛋白和植物提取物渗透头皮毛囊。Nitrogen oxides are needed for hair growth. Arginine can participate in the production of nitrogen compounds. In addition, it can expand the blood vessels in the scalp and increase the amount of nutrients and oxygen delivered to the hair follicles; bisabolol has high permeability in the skin cortex. Dozens of times that of commonly used penetrating agents, it can promote the penetration of yeast protein and plant extracts into scalp hair follicles.
在一些优选的实施方式中,所述pH调节剂选自柠檬酸钠、磷酸氢二钠、磷酸二氢钠中的一种或多种组合;优选的,所述pH调节剂为柠檬酸钠。In some preferred embodiments, the pH regulator is selected from one or more combinations of sodium citrate, disodium hydrogen phosphate, and sodium dihydrogen phosphate; preferably, the pH regulator is sodium citrate.
在一些优选的实施方式中,所述防腐剂选自苯氧乙醇、对羟基苯乙酮、苯甲酸钠、山梨酸钾、苯甲酸、脱氢乙酸中的一种或多种组合;优选的,所述防腐剂为苯氧乙醇和对羟基苯乙酮。In some preferred embodiments, the preservative is selected from one or more combinations of phenoxyethanol, p-hydroxyacetophenone, sodium benzoate, potassium sorbate, benzoic acid, and dehydroacetic acid; preferably, the The preservatives are phenoxyethanol and p-hydroxyacetophenone.
在一些优选的实施方式之中,所述苯氧乙醇和对羟基苯乙酮的重量比为(0.1-0.5):(0.1-1)。In some preferred embodiments, the weight ratio of phenoxyethanol to p-hydroxyacetophenone is (0.1-0.5):(0.1-1).
为了提高水解酵母蛋白和各种植物提取物之间更好的协同增效作用,在一些优选的实施方式中,水解酵母蛋白选自酿酒酵母蛋白的水解产物,蕴含十几种氨基酸,所述植物提取物A与水解酵母蛋白的重量比为(10-14):1。In order to improve the synergistic effect between hydrolyzed yeast protein and various plant extracts, in some preferred embodiments, the hydrolyzed yeast protein is selected from the hydrolyzate of Saccharomyces cerevisiae protein, which contains more than ten kinds of amino acids. The weight ratio of extract A to hydrolyzed yeast protein is (10-14):1.
水解酵母蛋白是酵母细胞的水解产物,通过自溶或通过外加酶水解得到。水解酵母产品中含有大量的氨基酸、小肽、丰富的B族维生素、谷胱甘肽及核苷酸类物质。水解酵母蛋白比较一般的酵母蛋白,水解酵母蛋白分子量更小,更容易渗透到皮脂腺,改善头皮油脂分泌旺盛问题;另外水解酵母蛋白与各种植物提取物协同还可以修复受损的毛囊细胞,促进毛囊细胞分裂,维持头皮毛囊细胞活性。Hydrolyzed yeast protein is the hydrolyzed product of yeast cells, which is obtained by autolysis or hydrolysis with external enzymes. Hydrolyzed yeast products contain a large amount of amino acids, small peptides, rich in B vitamins, glutathione and nucleotide substances. Compared with common yeast protein, hydrolyzed yeast protein has a smaller molecular weight and is easier to penetrate into the sebaceous glands, improving the problem of exuberant oil secretion in the scalp; in addition, hydrolyzed yeast protein and various plant extracts can also repair damaged hair follicle cells and promote hair growth. Hair follicle cells divide to maintain scalp hair follicle cell activity.
为了提高防脱控油舒缓精华液的稳定性,在一些优选的实施方式中,所述异十二烷与植物提取物B的重量比为(2-5):1。异十二烷是一种无色无味透明液体,具有良好的物理化学性质和毒性,几乎不含芳烃和硫磺,对眼、皮肤无刺激、无致敏性、对黑头粉刺无副作用;此重量比下的植物提取物B在异十二烷中的溶解度和配伍性优异,从而提高防脱控油舒缓精华液的稳定性。In order to improve the stability of the anti-dandruff control oil soothing essence, in some preferred embodiments, the weight ratio of the isododecane to the plant extract B is (2-5):1. Isododecane is a colorless, odorless, transparent liquid with good physical and chemical properties and toxicity, almost free of aromatics and sulfur, non-irritating to eyes and skin, non-sensitizing, and has no side effects on blackheads; this weight ratio The following plant extract B has excellent solubility and compatibility in isododecane, thereby improving the stability of the anti-dandruff control oil soothing essence.
在一些优选的实施方式中,所述增稠剂选自羟乙基纤维素、羟丙基纤维素、羟丙基甲基纤维素、甲基纤维素、羧甲基纤维素中的任意一种。In some preferred embodiments, the thickener is selected from any one of hydroxyethyl cellulose, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, methyl cellulose, carboxymethyl cellulose .
本发明第二方面提供了一种防脱控油舒缓精华液的制备方法,将各种原料按重量百分比混合均匀即得。The second aspect of the present invention provides a preparation method of anti-dandruff control oil soothing essence, which is prepared by mixing various raw materials uniformly according to weight percentage.
有益效果:本发明的防脱控油舒缓精华液采用多种植物提取物搭配水解酵母蛋白、维生素、抗菌剂和皮肤调理剂,能够有效抑制5a-还原酶活性、减少皮脂的产生;抑制马拉色菌过度繁殖、平衡头皮微生态环境;扩张头皮毛细血管、促进头皮血液循环、促进毛囊再生;本发明的防脱控油舒缓精华液采用水油双相体系既保留了水相和油相两种液体功效的同时,也提升了精华液体系的稳定性。Beneficial effects: the anti-dripping and oil-controlling soothing essence of the present invention uses a variety of plant extracts combined with hydrolyzed yeast protein, vitamins, antibacterial agents and skin conditioners, which can effectively inhibit the activity of 5a-reductase and reduce the production of sebum; inhibit Malassezia Bacteria overgrowth, balance the micro-ecological environment of the scalp; expand scalp capillaries, promote scalp blood circulation, and promote hair follicle regeneration; the anti-dandruff control oil soothing essence of the present invention adopts a water-oil dual-phase system to retain both the water phase and the oil phase While improving the efficacy, it also improves the stability of the essence system.
附图说明Description of drawings
图1为本发明实施例2所制备的防脱控油舒缓精华液的抑菌圈测试图。Fig. 1 is a test chart of the inhibition zone of the anti-shedding oil control soothing essence prepared in Example 2 of the present invention.
具体实施方式Detailed ways
实施例1Example 1
实施例1提供了一种防脱控油舒缓精华液,按重量百分比计,其原料包括:9%保湿剂、6%植物提取物A、4%植物提取物B、2%抗菌剂、2%维生素、1%皮肤调理剂、0.5%pH调节剂、0.5%水解酵母蛋白、0.5%防腐剂、0.3%香精、0.3%增稠剂、20%乙醇、8%异十二烷、去离子水余量。Embodiment 1 provides a kind of anti-dandruff control oil soothing essence, by weight percentage, its raw material comprises: 9% humectant, 6% plant extract A, 4% plant extract B, 2% antibacterial agent, 2% vitamin , 1% skin conditioning agent, 0.5% pH regulator, 0.5% hydrolyzed yeast protein, 0.5% preservative, 0.3% essence, 0.3% thickener, 20% ethanol, 8% isododecane, deionized water balance .
所述保湿剂为1,2-己二醇(CAS号:6920-22-5)、1,3-丙二醇(CAS号504-63-2)、辛甘醇(CAS号:1117-86-8)和透明质酸钠;所述透明质酸钠的分子量为200kDa~400kDa,购买自华熙生物科技股份有限公司;所述1,2-己二醇、1,3-丙二醇、辛甘醇和透明质酸钠的重量比为1:3:0.5:0.1。The moisturizing agent is 1,2-hexanediol (CAS No.: 6920-22-5), 1,3-propylene glycol (CAS No. 504-63-2), caprylyl glycol (CAS No.: 1117-86-8 ) and sodium hyaluronate; the molecular weight of the sodium hyaluronate is 200kDa ~ 400kDa, purchased from Bloomage Biotechnology Co., Ltd.; the 1,2-hexanediol, 1,3-propanediol, caprylyl glycol and transparent The weight ratio of sodium hyphenate is 1:3:0.5:0.1.
所述植物提取物A为苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物、姜根提取物、红车轴草叶提取物和艾叶提取物;所述苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物、姜根提取物、红车轴草叶提取物、艾叶提取物的重量比为2:2:1:0.6:0.18:0.03:0.03;所述苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物均购买自湖州湖星日化有限公司;所述姜根提取物、红车轴草叶提取物和艾叶提取物均购买自上海珈凯生物科技有限公司。The plant extract A is Sophora flavescens extract, ginseng extract, burdock root extract, arborvitae leaf extract, ginger root extract, red clover leaf extract and mugwort leaf extract; the Sophora flavescens extract, ginseng extract, burdock root extract, arborvitae leaf extract, ginger root extract, red clover leaf extract, Artemisia argyi leaf extract weight ratio is 2:2:1:0.6:0.18:0.03:0.03; Extract, ginseng extract, burdock root extract, and orientalis leaf extract were all purchased from Huzhou Huxing Daily Chemical Co., Ltd.; the ginger root extract, red clover leaf extract and mugwort leaf extract were all purchased from Shanghai Jiakai Biological Technology Co., Ltd.
所述植物提取物B包括油橄榄果油、沙棘籽油、樱花油、薰衣草油、薄荷脑;所述油橄榄果油、沙棘籽油、樱花油、薰衣草油、薄荷脑的重量比为1:1:0.3:0.4:0.4;所述油橄榄果油和沙棘籽油购买自Vantage Specialty Chemicals,Inc.;所述樱花油、薰衣草油购买自广州粤泽化工有限公司;薄荷脑购买自安徽一帆香料有限公司。The plant extract B includes olive oil, seabuckthorn seed oil, cherry blossom oil, lavender oil, and menthol; the weight ratio of the olive oil, seabuckthorn seed oil, cherry blossom oil, lavender oil, and menthol is 1:1: 0.3:0.4:0.4; the olive fruit oil and seabuckthorn seed oil were purchased from Vantage Specialty Chemicals, Inc.; the cherry blossom oil and lavender oil were purchased from Guangzhou Yueze Chemical Co., Ltd.; menthol was purchased from Anhui Yifan Perfume Co., Ltd. .
所述抗菌剂为甘草酸二钾(CAS号:68797-35-3)和乙基己基甘油(CAS号:70445-33-9);所述甘草酸二钾和乙基己基甘油的重量比为1:0.3。Described antibacterial agent is Dipotassium Glycyrrhizinate (CAS No.: 68797-35-3) and ethylhexylglycerin (CAS No.: 70445-33-9); The weight ratio of described Dipotassium Glycyrrhizinate and ethylhexylglycerin is 1:0.3.
所述维生素为泛醇、生物素和维生素E;所述泛醇、生物素和维生素E的重量比为1:0.1:1;所述泛醇和维生素E购买自巴斯夫(中国)有限公司;所述生物素购买自帝斯曼(中国)有限公司。The vitamins are panthenol, biotin and vitamin E; the weight ratio of the panthenol, biotin and vitamin E is 1:0.1:1; the panthenol and vitamin E are purchased from BASF (China) Co., Ltd.; the Biotin was purchased from DSM (China) Co., Ltd.
所述皮肤调理剂包括精氨酸和红没药醇;所述精氨酸和红没药醇的重量比为1:1;所述精氨酸购买自德之馨香精香料(南通)有限公司;所述红没药醇购买自巴斯夫(中国)有限公司。The skin conditioning agent includes arginine and bisabolol; the weight ratio of the arginine and bisabolol is 1:1; the arginine is purchased from Dezhixin Flavors and Fragrances (Nantong) Co., Ltd. ; The bisabolol was purchased from BASF (China) Co., Ltd.
所述pH调节剂为柠檬酸钠(CAS号:68-04-2)。The pH regulator is sodium citrate (CAS number: 68-04-2).
所述防腐剂为苯氧乙醇(CAS号:122-99-6)和对羟基苯乙酮(CAS号:99-93-4);所述苯氧乙醇和对羟基苯乙酮的重量比为3:1。Described preservative is phenoxyethanol (CAS number: 122-99-6) and p-hydroxyacetophenone (CAS number: 99-93-4); The weight ratio of described phenoxyethanol and p-hydroxyacetophenone is 3:1.
所述香精购买自铭康香精香料有限公司。The essence was purchased from Mingkang Flavor and Fragrance Co., Ltd.
所述增稠剂为羟乙基纤维素(CAS号:9004-62-0),购买自陶氏(张家港)投资有限公司。The thickener is hydroxyethyl cellulose (CAS No.: 9004-62-0), purchased from Dow (Zhangjiagang) Investment Co., Ltd.
所述异十二烷(CAS号:31807-55-3),购买自淄博润福化工科技有限公司。The isododecane (CAS No.: 31807-55-3) was purchased from Zibo Runfu Chemical Technology Co., Ltd.
所述水解酵母蛋白购买自亚什兰(中国)投资有限公司。The hydrolyzed yeast protein was purchased from Ashland (China) Investment Co., Ltd.
一种防脱控油舒缓精华液的制备方法包括以下步骤:A preparation method of anti-dripping and oil-controlling soothing essence comprises the following steps:
(1)将1,2-己二醇、1,3-丙二醇、辛甘醇、苯氧乙醇和对羟基苯乙酮、苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物、姜根提取物、红车轴草叶提取物、艾叶提取物、甘草酸二钾、乙基己基甘油以及水解酵母蛋白溶于乙醇中分散均匀,备用。(1) 1,2-hexanediol, 1,3-propanediol, caprylyl glycol, phenoxyethanol and p-hydroxyacetophenone, flavescens extract, ginseng extract, burdock root extract, and arborvitae leaf extract , ginger root extract, red clover leaf extract, mugwort leaf extract, dipotassium glycyrrhizinate, ethylhexylglycerin and hydrolyzed yeast protein are dissolved in ethanol and dispersed evenly, and set aside.
(2)将羟乙基纤维素加入去离子水中,加热至70℃,完全溶解后加入泛醇、生物素、透明质酸钠、维生素E、柠檬酸钠、精氨酸、红没药醇和步骤(1)得到的混合物,搅拌均匀至透明得水相。(2) Add hydroxyethyl cellulose to deionized water, heat to 70°C, add panthenol, biotin, sodium hyaluronate, vitamin E, sodium citrate, arginine, bisabolol and step (1) The obtained mixture was stirred evenly until a transparent aqueous phase was obtained.
(3)将油橄榄果油、沙棘籽油、樱花油、薰衣草油、薄荷脑和香精溶于异十二烷中,搅拌均匀至透明得油相。(3) Dissolve olive fruit oil, seabuckthorn seed oil, cherry blossom oil, lavender oil, menthol and essence in isododecane, and stir until transparent to obtain an oil phase.
(4)将步骤(2)所得水相和步骤(3)所得油相按比例进行灌装即得。(4) The water phase obtained in step (2) and the oil phase obtained in step (3) are filled in proportion to obtain the product.
所述步骤(4)中水相和油相的灌装体积比例为2:1。The filling volume ratio of the water phase and the oil phase in the step (4) is 2:1.
制备得到的防脱控油舒缓精华液上层油相为黄色透明液体,下层水相为浅黄色透明液体。The prepared anti-dandruff control soothing essence liquid has an upper layer oil phase which is a yellow transparent liquid, and a lower layer water phase which is a light yellow transparent liquid.
实施例2Example 2
实施例2提供了一种防脱控油舒缓精华液,按重量百分比计,其原料包括:5%保湿剂、4%植物提取物A、0.5%植物提取物B、2%抗菌剂、1.1%维生素、1.5%皮肤调理剂、0.5%pH调节剂、3%水解酵母蛋白、0.6%防腐剂、0.3%香精、0.3%增稠剂、20%乙醇、5%PEG-40氢化蓖麻油、去离子水余量。Embodiment 2 provides a kind of anti-dandruff control oil soothing essence, by weight percentage, its raw material comprises: 5% humectant, 4% plant extract A, 0.5% plant extract B, 2% antibacterial agent, 1.1% vitamin , 1.5% skin conditioning agent, 0.5% pH regulator, 3% hydrolyzed yeast protein, 0.6% preservative, 0.3% essence, 0.3% thickener, 20% ethanol, 5% PEG-40 hydrogenated castor oil, deionized water margin.
所述保湿剂为1,2-己二醇(CAS号:6920-22-5)、1,3-丙二醇(CAS号504-63-2)和辛甘醇(CAS号:1117-86-8)所述1,2-己二醇、1,3-丙二醇和辛甘醇的重量比为1:1:0.2。The humectant is 1,2-hexanediol (CAS No.: 6920-22-5), 1,3-propanediol (CAS No. 504-63-2) and caprylyl glycol (CAS No.: 1117-86-8 ) The weight ratio of 1,2-hexanediol, 1,3-propanediol and caprylyl glycol is 1:1:0.2.
所述植物提取物A为苦参提取物和侧柏叶提取物;所述苦参提取物和侧柏叶提取物的重量比为1:1;所述苦参提取物和侧柏叶提取物均购买自湖州湖星日化有限公司。The plant extract A is Sophora flavescens extract and cypress leaf extract; the weight ratio of flavescens extract and cypress leaf extract is 1:1; the flavescens extract and cypress leaf extract All were purchased from Huzhou Huxing Daily Chemical Co., Ltd.
所述植物提取物B为薄荷脑;所述薄荷脑购买自安徽一帆香料有限公司。The plant extract B is menthol; the menthol is purchased from Anhui Yifan Perfume Co., Ltd.
所述抗菌剂为甘草酸二钾(CAS号:68797-35-3)、乙基己基甘油(CAS号:70445-33-9)和吡罗克酮乙醇胺盐;所述甘草酸二钾、乙基己基甘油和吡罗克酮乙醇胺盐的重量比为1:0.3:0.05;所述吡罗克酮乙醇胺盐购买自上海寰球实业发展有限公司。The antibacterial agent is Dipotassium Glycyrrhizinate (CAS No.: 68797-35-3), ethylhexylglycerin (CAS No.: 70445-33-9) and piroctone olamine salt; The weight ratio of hexylglycerin and piroctone olamine salt is 1:0.3:0.05; the piroctone olamine salt is purchased from Shanghai Huanqiu Industrial Development Co., Ltd.
所述维生素为泛醇和生物素;所述泛醇和生物素的重量比为10:1;所述泛醇购买自巴斯夫(中国)有限公司;所述生物素购买自帝斯曼(中国)有限公司。The vitamins are panthenol and biotin; the weight ratio of the panthenol and biotin is 10:1; the panthenol is purchased from BASF (China) Co., Ltd.; the biotin is purchased from DSM (China) Co., Ltd. .
所述皮肤调理剂包括葡萄糖酸锌和烟酰胺;所述葡萄糖酸锌和烟酰胺的重量比为2:1;所述葡萄糖酸锌购买自巴斯夫(中国)有限公司;所述烟酰胺购买自苏州龙沙化工有限公司。The skin conditioner includes zinc gluconate and nicotinamide; the weight ratio of zinc gluconate and nicotinamide is 2:1; the zinc gluconate is purchased from BASF (China) Co., Ltd.; the nicotinamide is purchased from Suzhou Lonza Chemical Co., Ltd.
所述pH调节剂为柠檬酸钠(CAS号:68-04-2)。The pH regulator is sodium citrate (CAS number: 68-04-2).
所述防腐剂为苯氧乙醇(CAS号:122-99-6)和对羟基苯乙酮(CAS号:99-93-4);所述苯氧乙醇和对羟基苯乙酮的重量比为3:1。Described preservative is phenoxyethanol (CAS number: 122-99-6) and p-hydroxyacetophenone (CAS number: 99-93-4); The weight ratio of described phenoxyethanol and p-hydroxyacetophenone is 3:1.
所述香精购买自芬美意香料(中国)有限公司。The essence was purchased from Firmenich Fragrances (China) Co., Ltd.
所述增稠剂为羟乙基纤维素(CAS号:9004-62-0),购买自陶氏(张家港)投资有限公司。The thickener is hydroxyethyl cellulose (CAS No.: 9004-62-0), purchased from Dow (Zhangjiagang) Investment Co., Ltd.
所述PEG-40氢化蓖麻油,购买自巴斯夫(中国)有限公司。The PEG-40 hydrogenated castor oil was purchased from BASF (China) Co., Ltd.
所述水解酵母蛋白购买自亚什兰(中国)投资有限公司。The hydrolyzed yeast protein was purchased from Ashland (China) Investment Co., Ltd.
一种防脱控油舒缓精华液的制备方法包括以下步骤:A preparation method of anti-dripping and oil-controlling soothing essence comprises the following steps:
(1)将1,2-己二醇、1,3-丙二醇、辛甘醇、苯氧乙醇、对羟基苯乙酮、苦参提取物、侧柏叶提取物、甘草酸二钾、乙基己基甘油、吡罗克酮乙醇胺盐以及水解酵母蛋白溶于乙醇中分散均匀,备用。(1) 1,2-hexanediol, 1,3-propanediol, caprylyl glycol, phenoxyethanol, p-hydroxyacetophenone, Sophora flavescens extract, cypress leaf extract, dipotassium glycyrrhizinate, ethyl Hexylglycerin, piroctone olamine salt and hydrolyzed yeast protein are dissolved in ethanol and dispersed evenly, and set aside.
(2)将羟乙基纤维素加入去离子水中,加热至70℃,完全溶解后加入泛醇、生物素、柠檬酸钠、葡萄糖酸锌、烟酰胺、步骤(1)得到的混合物、薄荷脑、氢化蓖麻油和香精,搅拌均匀即得,料液为浅黄色透明液体。(2) Add hydroxyethyl cellulose to deionized water, heat to 70°C, add panthenol, biotin, sodium citrate, zinc gluconate, nicotinamide, the mixture obtained in step (1), and menthol after completely dissolving , hydrogenated castor oil and essence, stir evenly, and the material liquid is light yellow transparent liquid.
实施例3Example 3
实施例3提供了一种防脱控油舒缓精华液,其具体实施方式同实施例1,不同点在于,所述苦参提取物、人参提取物、牛蒡提取物、侧柏叶提取物、姜根提取物、红车轴草叶提取物、艾叶提取物的重量比为3:3:0.5:1:0.5:0.5:0.5。Embodiment 3 provides a kind of anti-dandruff control oil soothing essence, its specific implementation is the same as embodiment 1, the difference is that the Sophora flavescens extract, ginseng extract, burdock extract, orientalis leaf extract, ginger root The weight ratio of the extract, the red clover leaf extract and the mugwort leaf extract is 3:3:0.5:1:0.5:0.5:0.5.
实施例4Example 4
实施例4提供了一种防脱控油舒缓精华液,其具体实施方式同实施例1,不同点在于,所述保湿剂为1,2-己二醇和1,3-丙二醇;所述1,2-己二醇和1,3-丙二醇的重量比为1:3。Embodiment 4 provides a kind of anti-dripping and oil-controlling soothing essence, its specific embodiment is the same as embodiment 1, the difference is that the moisturizer is 1,2-hexanediol and 1,3-propylene glycol; the 1,2 - The weight ratio of hexanediol and 1,3-propanediol is 1:3.
实施例5Example 5
实施例5提供了一种防脱控油舒缓精华液,其具体实施方式同实施例1,不同点在于,所述异十二烷的重量百分比为4%。Example 5 provides an anti-dandruff control oil soothing essence, the specific implementation of which is the same as that of Example 1, except that the weight percentage of the isododecane is 4%.
实施例6Example 6
实施例6提供了一种防脱控油舒缓精华液,其具体实施方式同实施例1,不同点在于,所述步骤(4)中水相和油相的灌装体积比例为1:2。Example 6 provides an anti-dripping and oil-controlling soothing essence, the specific implementation method of which is the same as that of Example 1, except that the filling volume ratio of the water phase and the oil phase in the step (4) is 1:2.
性能测试方法performance test method
1、稳定性测试:将实施例1-6所制备的防脱控油舒缓精华液设置2份平行样,将平行样分别置于25℃和40℃下各放置1个月进行稳定性测定,结果见表1。1. Stability test: Set 2 parallel samples of the anti-shedding oil control soothing essence prepared in Examples 1-6, and place the parallel samples at 25°C and 40°C for 1 month respectively for stability measurement, the results See Table 1.
2、水油分层情况:将实施例1、实施例3-6所制备的防脱控油舒缓精华液置于100mL的具塞量筒中,以相同的速度上下摇晃20次,静置观察,记录5分钟后界面清晰度、是否有油珠挂壁现象,结果见表1。2. Water and oil layering situation: put the anti-shedding and oil-controlling soothing essence prepared in Example 1 and Example 3-6 into a 100mL stoppered measuring cylinder, shake it up and down 20 times at the same speed, stand for observation, and record After 5 minutes, the clarity of the interface and whether there are oil droplets hanging on the wall, the results are shown in Table 1.
表1:Table 1:
3、功效测试:选取48名有头皮不适情况的志愿者,不限男女,试用实施例1所述的防脱控油舒缓精华液。使用方法为:取适量本品均匀涂抹于头皮,轻轻用手或头皮按摩器按摩,每天使用一次且不必冲洗;单次用量为6ml。3. Efficacy test: 48 volunteers with scalp discomfort, not limited to men and women, were selected to try the anti-shedding and oil-controlling soothing essence described in Example 1. How to use: Take an appropriate amount of this product and apply it evenly on the scalp, massage gently with your hands or a scalp massager, use it once a day without rinsing; the single dosage is 6ml.
测试结果:37名志愿者觉得使用后头发清爽,35名志愿者觉得使用后几乎没有头屑,32名志愿者觉得使用后几乎没有痒感,20名志愿者觉得使用后头发柔顺、蓬松;42名志愿者认为样品具有舒缓头皮的效果,40名志愿者认为样品具有改善头痒、小疙瘩的效果。Test results: 37 volunteers felt that the hair was refreshing after use, 35 volunteers felt that there was almost no dandruff after use, 32 volunteers felt that there was almost no itching after use, 20 volunteers felt that the hair was soft and fluffy after use; 42 40 volunteers believed that the sample had the effect of improving scalp itching and small bumps.
4、抑菌效果测试步骤如表2,结果如表3和图1所示。4. The test steps for antibacterial effect are shown in Table 2, and the results are shown in Table 3 and Figure 1.
表2:Table 2:
表3:table 3:
5、使用感受测试:选取14名具有掉发显著(可参考每天掉发平均根数≥30根)的自愿者,不限男女,试用实施例1-4所述的防脱控油舒缓精华液4天(每个实施例),接着重复以上操作一次(二次)。使用方法为:在头发半干状态,按6ml/次全头按摩3-5分钟,每天一次。由功效评价人员填写志愿者单次、二次使用感受(香型、颜色、浓稠程度、清爽感等):5分-很满意,4分-满意,3分-一般,2分-不满意,1分-很不满意,以下数值为平均值(四舍五入保留小数点后一位)测试结果见表4。5. Use experience test: Select 14 volunteers who have significant hair loss (refer to the average number of hair loss ≥ 30 hairs per day), not limited to men and women, and try the anti-hair loss control oil soothing essence 4 described in Examples 1-4 Day (every example), then repeat the above operation once (twice). The method of use is: in the semi-dry state of the hair, press 6ml/time and massage the whole head for 3-5 minutes, once a day. Efficacy evaluators fill in volunteers’ single and secondary use feelings (fragrance, color, thickness, refreshing feeling, etc.): 5 points-very satisfied, 4 points-satisfied, 3 points-average, 2 points-dissatisfied , 1 point-very dissatisfied, the following values are average values (rounded to one decimal place) and the test results are shown in Table 4.
表4:Table 4:
志愿者使用实施例1反馈:1、12人觉得在使用过程中头皮清凉舒爽,2人无头皮清凉舒爽的感觉;2、3人觉得质地偏稀,水状流动速度快,11人觉得质地适中;3、7人觉得用量偏多,2人觉得用量偏少,5人觉得用量适中。Feedback from volunteers using Example 1: 1. 12 people feel that the scalp is cool and refreshing during use, and 2 people feel that the scalp is not cool and refreshing; The texture is moderate; 3 and 7 people think the dosage is too much, 2 people think the dosage is too little, and 5 people think the dosage is moderate.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211405303.2A CN116265007A (en) | 2022-11-10 | 2022-11-10 | Anti-drop oil-control and soothing essence and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211405303.2A CN116265007A (en) | 2022-11-10 | 2022-11-10 | Anti-drop oil-control and soothing essence and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116265007A true CN116265007A (en) | 2023-06-20 |
Family
ID=86744217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211405303.2A Pending CN116265007A (en) | 2022-11-10 | 2022-11-10 | Anti-drop oil-control and soothing essence and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116265007A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117695368A (en) * | 2023-12-19 | 2024-03-15 | 肇庆迪彩日化科技有限公司 | Alopecia preventing composition and preparation method and application thereof |
| CN118045020A (en) * | 2024-04-08 | 2024-05-17 | 珠海博御中医药研究有限公司 | Alopecia preventing composition and preparation method and application thereof |
| CN118370710A (en) * | 2024-06-21 | 2024-07-23 | 科乐美(广州)生物科技有限公司 | Dual-purpose hair and skin oil control composition and preparation method and application thereof |
| CN118831028A (en) * | 2024-08-23 | 2024-10-25 | 佛山市一沁生物科技有限公司 | Anti-hair loss essence and preparation method thereof |
| CN119868238A (en) * | 2025-03-28 | 2025-04-25 | 舒芙雅生物科技有限公司 | Chinese herbal medicine acne-removing composition and preparation method thereof |
| WO2025176220A1 (en) * | 2024-02-22 | 2025-08-28 | 上海珈凯生物股份有限公司 | Alopecia-preventing plant extract, and preparation method therefor and use thereof |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106667879A (en) * | 2015-11-06 | 2017-05-17 | 万淑香 | Aleurites moluccana seed oil nourishing conditioner |
| CN110934752A (en) * | 2019-12-05 | 2020-03-31 | 广州立白企业集团有限公司 | Hair care essence composition and preparation method thereof |
| CN111700843A (en) * | 2020-07-14 | 2020-09-25 | 孙开军 | Hair loss preventing and hair nourishing shampoo and preparation method thereof |
| CN114209632A (en) * | 2022-01-26 | 2022-03-22 | 拉芳家化股份有限公司 | Pre-washing hair-fixing essential oil |
| CN114259446A (en) * | 2022-01-26 | 2022-04-01 | 拉芳家化股份有限公司 | Scalp essence containing nourishing complexing agent |
| CN115192505A (en) * | 2022-07-25 | 2022-10-18 | 浙江浩迈科技有限公司 | A kind of anti-stripping mixed solution and preparation method thereof |
-
2022
- 2022-11-10 CN CN202211405303.2A patent/CN116265007A/en active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106667879A (en) * | 2015-11-06 | 2017-05-17 | 万淑香 | Aleurites moluccana seed oil nourishing conditioner |
| CN110934752A (en) * | 2019-12-05 | 2020-03-31 | 广州立白企业集团有限公司 | Hair care essence composition and preparation method thereof |
| CN111700843A (en) * | 2020-07-14 | 2020-09-25 | 孙开军 | Hair loss preventing and hair nourishing shampoo and preparation method thereof |
| CN114209632A (en) * | 2022-01-26 | 2022-03-22 | 拉芳家化股份有限公司 | Pre-washing hair-fixing essential oil |
| CN114259446A (en) * | 2022-01-26 | 2022-04-01 | 拉芳家化股份有限公司 | Scalp essence containing nourishing complexing agent |
| CN115192505A (en) * | 2022-07-25 | 2022-10-18 | 浙江浩迈科技有限公司 | A kind of anti-stripping mixed solution and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 王建新: "《化妆品植物原料大全》", 30 June 2012, 中国纺织出版社, pages: 130 - 131 * |
| 董淑炎等: "《"健美益寿天然食品》", 31 March 1991, 中国旅游出版社, pages: 423 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117695368A (en) * | 2023-12-19 | 2024-03-15 | 肇庆迪彩日化科技有限公司 | Alopecia preventing composition and preparation method and application thereof |
| WO2025176220A1 (en) * | 2024-02-22 | 2025-08-28 | 上海珈凯生物股份有限公司 | Alopecia-preventing plant extract, and preparation method therefor and use thereof |
| CN118045020A (en) * | 2024-04-08 | 2024-05-17 | 珠海博御中医药研究有限公司 | Alopecia preventing composition and preparation method and application thereof |
| CN118370710A (en) * | 2024-06-21 | 2024-07-23 | 科乐美(广州)生物科技有限公司 | Dual-purpose hair and skin oil control composition and preparation method and application thereof |
| CN118831028A (en) * | 2024-08-23 | 2024-10-25 | 佛山市一沁生物科技有限公司 | Anti-hair loss essence and preparation method thereof |
| CN119868238A (en) * | 2025-03-28 | 2025-04-25 | 舒芙雅生物科技有限公司 | Chinese herbal medicine acne-removing composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN116265007A (en) | Anti-drop oil-control and soothing essence and preparation method thereof | |
| CN112656732B (en) | Dandruff-removing and itching-relieving shampoo and preparation method thereof | |
| JPWO2004016236A1 (en) | Cosmetics | |
| CN110934783A (en) | Dandruff-removing and itching-relieving composition containing Chinese herbal medicines, silicone oil-free amino acid shampoo containing composition, and preparation method and application of silicone oil-free amino acid shampoo | |
| JP2003531860A (en) | Olive seed plant extract and its use as NO synthase inhibitors | |
| HU193777B (en) | Preparation against acne and process for preparing the same | |
| CN113171327A (en) | Oil-control acne-removing composition and application thereof | |
| CN118831028A (en) | Anti-hair loss essence and preparation method thereof | |
| JP2003532644A (en) | Plant extracts of Vitis vinifera species as NO synthase inhibitors and their use | |
| CN120078692A (en) | An anti-hair loss shampoo with effective antibacterial and oil control function and preparation method thereof | |
| KR102220534B1 (en) | Soothing cream and manufacturing method for the same | |
| FR2829928A1 (en) | Cosmetic composition, useful for skin and hair care, comprises water-soluble extracts of galangal, holy-grass and purslane | |
| KR20100074880A (en) | Shampoo composition for promoting restoring hair and preventing from losing hair | |
| CN104287982B (en) | Dandruff removal composition for adjusting oil balance of scalp | |
| KR20150122983A (en) | Comsmetic composition comprising mint vinegar | |
| JPH03112912A (en) | Cosmetic composition | |
| RU2334522C1 (en) | Medicinal and preventive elixir for oral cavity care | |
| CN112315855A (en) | Anti-hair loss and hair-nourishing composition and preparation method and application thereof | |
| CN115429738B (en) | A kind of anti-acne, repairing and revitalizing essence and preparation method thereof | |
| KR20210072966A (en) | Nanocapsule composition for skin moisturizing or skin inflammatory improvement comprsing encapsulated centella and calamine | |
| KR100610951B1 (en) | Composition for Skin-antiacne | |
| KR20150116504A (en) | A cosmetics composition containing tea tree and solt | |
| CN116270382A (en) | Scalp care composition with effects of preventing alopecia, removing dandruff, controlling oil and relieving itching | |
| WO2013054760A1 (en) | Cosmetic | |
| KR100909729B1 (en) | Cosmetic composition for preventing and improving acne containing Namsil extract |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |